Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    New entries published: MDNA11 clinical trial results at the ESMO-IO Congress (Dec 10, 2025) and a live webinar to discuss updated MDNA11 data (Dec 9, 2025). Older items removed: Oct 1, 2025 ROTH Healthcare Opportunities Conference participation and Sep 25, 2025 Annual Shareholders Meeting results.
    Difference
    4%
    Check dated 2025-12-15T20:11:59.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added November 13, 2025 entry: Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update. Removed September 5, 2025 entry: Medicenna Therapeutics to Participate at the H.C. Wainwright 27th Annual Global Investment Conference.
    Difference
    3%
    Check dated 2025-11-17T06:10:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a November 6, 2025 news release about Medicenna and Fondazione Melanoma Onlus collaboration; removed the August 1, 2025 press release on the Q1 FY2026 financial results.
    Difference
    3%
    Check dated 2025-11-10T01:58:19.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a new News Release dated October 23, 2025 about updated MDNA11 clinical data to be presented at the ESMO Immuno-Oncology Congress 2025. Deleted the earlier News Release dated July 31, 2025 announcing five patents granted for IL-2 and IL-4 superkines.
    Difference
    3%
    Check dated 2025-10-26T20:19:37.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    - Add: new date (October 1, 2025) and announcement of Medicenna’s participation in the ROTH Healthcare Opportunities Conference. - Remove: old date (April 30, 2025) and the previous AACR preclinical data press release.
    Difference
    50%
    Check dated 2025-10-05T06:36:31.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Changed focus from ABILITY-1 trial results announced at AACR 2025 and an April 28, 2025 date to Medicenna’s annual meeting result announced on September 25, 2025 (and page 3 reference).
    Difference
    51%
    Check dated 2025-09-28T02:50:29.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.